Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-16 4:03 pm Sale | 2025-09-30 | 13G | Beta Bionics, Inc. BBNX | ICS Opportunities, Ltd. | 796,964 1.800% | -1,489,764 (-65.15%) | Filing History |
| 2025-10-15 4:16 pm Sale | 2025-09-30 | 13G | The Hain Celestial Group, Inc. HAIN | ICS Opportunities, Ltd. | 2,242,259 2.500% | -2,425,371 (-51.96%) | Filing History |
| 2025-10-14 4:05 pm Sale | 2025-09-30 | 13G | Pyxis Oncology, Inc. PYXS | ICS Opportunities, Ltd. | 818,134 1.300% | -2,724,529 (-76.91%) | Filing History |
| 2025-10-14 4:00 pm Sale | 2025-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | ICS Opportunities, Ltd. | 902,521 1.300% | -2,878,777 (-76.13%) | Filing History |
| 2025-10-08 4:17 pm Purchase | 2025-10-02 | 13G | ALX Oncology Holdings Inc. ALXO | ICS Opportunities, Ltd. | 2,707,151 5.100% | 704,777 (+35.20%) | Filing History |
| 2025-10-07 4:07 pm Purchase | 2025-09-30 | 13G | loanDepot, Inc. LDI | ICS Opportunities, Ltd. | 5,862,296 5.200% | 5,862,296 (New Position) | Filing History |
| 2025-09-23 4:00 pm Purchase | 2025-09-16 | 13G | AnaptysBio, Inc. ANAB | ICS Opportunities, Ltd. | 1,426,893 5.100% | 1,426,893 (New Position) | Filing History |
| 2025-09-22 4:00 pm Purchase | 2025-09-16 | 13G | Vermilion Energy Inc. VET | ICS Opportunities, Ltd. | 8,529,081 5.500% | 67,819 (+0.80%) | Filing History |
| 2025-09-19 4:21 pm Purchase | 2025-09-15 | 13G | Beta Bionics, Inc. BBNX | ICS Opportunities, Ltd. | 2,286,728 5.300% | 2,286,728 (New Position) | Filing History |
| 2025-09-18 5:19 pm Purchase | 2025-09-12 | 13G | Strive, Inc. ASST | ICS Opportunities, Ltd. | 22,421,052 6.000% | 22,421,052 (New Position) | Filing History |
| 2025-09-16 4:17 pm Purchase | 2025-09-10 | 13G | Constellium SE CSTM | ICS Opportunities, Ltd. | 7,453,770 5.300% | 2,331,404 (+45.51%) | Filing History |
| 2025-08-29 4:00 pm Purchase | 2025-08-25 | 13G | Murphy USA Inc. MUSA | ICS Opportunities, Ltd. | 926,541 4.800% | 926,541 (New Position) | Filing History |
| 2025-08-25 4:12 pm Purchase | 2025-08-19 | 13G | Phathom Pharmaceuticals, Inc. PHAT | ICS Opportunities, Ltd. | 4,160,515 5.900% | 398,471 (+10.59%) | Filing History |
| 2025-08-14 4:00 pm Purchase | 2025-08-12 | 13G | Highview Merger Corp. Units HVMCU | ICS Opportunities, Ltd. | 1,350,000 5.700% | 1,350,000 (New Position) | Filing History |
| 2025-08-13 4:00 pm Purchase | 2025-08-11 | 13G | Phathom Pharmaceuticals, Inc. PHAT | ICS Opportunities, Ltd. | 3,762,044 5.300% | 3,762,044 (New Position) | Filing History |
| 2025-08-12 4:20 pm Sale | 2025-06-30 | 13G | 10x Genomics, Inc. TXG | ICS Opportunities, Ltd. | 3,060,859 2.700% | -2,472,759 (-44.69%) | Filing History |
| 2025-08-11 4:06 pm Purchase | 2025-08-04 | 13G | WW International, Inc. WW | ICS Opportunities, Ltd. | 437,594 4.400% | 437,594 (New Position) | Filing History |
| 2025-08-08 4:08 pm Sale | 2025-06-30 | 13G | The Chemours Company CC | ICS Opportunities, Ltd. | 7,576,095 5.100% | -1,513,470 (-16.65%) | Filing History |
| 2025-08-04 4:01 pm Sale | 2025-06-30 | 13G | Dycom Industries, Inc. DY | ICS Opportunities, Ltd. | 1,095,359 3.800% | -282,332 (-20.49%) | Filing History |
| 2025-08-01 4:28 pm Sale | 2025-06-30 | 13G | Constellium SE CSTM | ICS Opportunities, Ltd. | 5,122,366 3.700% | -2,112,530 (-29.20%) | Filing History |